Janus Henderson Group PLC Biomarin Pharmaceutical Inc Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 14,051 shares of BMRN stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,051

Previous 696,518 97.98%

Holding current value

$1 Million

Previous $60.8 Million 98.1%

% of portfolio

0.0%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $50.8 Million - $62.9 Million	-682,467 Reduced 97.98%	14,051 $1.16 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $175 Million - $207 Million	-2,093,825 Reduced 75.04%	696,518 $60.8 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $48.3 Million - $62.5 Million	-634,196 Reduced 18.52%	2,790,343 $269 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $2.97 Million - $3.3 Million	34,893 Added 1.03%	3,424,539 $303 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $4.13 Million - $4.78 Million	-47,638 Reduced 1.39%	3,389,646 $294 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $39.6 Million - $52.9 Million	-451,160 Reduced 11.6%	3,437,284 $334 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $19.5 Million - $26.2 Million	-241,280 Reduced 5.84%	3,888,444 $402 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $5.88 Million - $6.93 Million	-71,509 Reduced 1.7%	4,129,724 $350 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $11.3 Million - $13.8 Million	-158,551 Reduced 3.64%	4,201,233 $348 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $34.6 Million - $43.2 Million	465,547 Added 11.95%	4,359,784 $336 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $3.9 Million - $4.98 Million	-54,444 Reduced 1.38%	3,894,237 $344 Million
Q3 2021 Nov 16, 2021	SELL	$74.77 - $85.47 $411,907 - $470,854	-5,509 Reduced 0.14%	3,948,681 $305 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $78.5 Million - $88.1 Million	-1,039,465 Reduced 20.82%	3,954,190 $330 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $51.8 Million - $62.9 Million	-693,287 Reduced 12.19%	4,993,655 $377 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $34.3 Million - $42.6 Million	472,232 Added 9.06%	5,686,942 $499 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $260 Million - $474 Million	3,618,749 Added 226.74%	5,214,710 $397 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $36.9 Million - $57.6 Million	463,882 Added 40.98%	1,595,961 $197 Million
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $77 Million - $104 Million	1,078,721 Added 2021.67%	1,132,079 $95.7 Million
Q4 2019 Feb 18, 2020	SELL	$64.27 - $86.37 $96,662 - $129,900	-1,504 Reduced 2.74%	53,358 $4.51 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $50,617 - $63,917	-751 Reduced 1.35%	54,862 $3.7 Million
Q2 2019 Jul 31, 2019	BUY	$80.35 - $93.9 $799,723 - $934,586	9,953 Added 21.8%	55,613 $4.76 Million
Q1 2019 Apr 30, 2019	BUY	$84.2 - $98.62 $68,370 - $80,079	812 Added 1.81%	45,660 $4.05 Million
Q4 2018 Feb 06, 2019	SELL	$80.14 - $106.07 $12,581 - $16,652	-157 Reduced 0.35%	44,848 $3.82 Million
Q3 2018 Nov 09, 2018	BUY	$93.92 - $105.72 $47,053 - $52,965	501 Added 1.13%	45,005 $4.37 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $912,230 - $1.07 Million	11,318 Added 34.1%	44,504 $0
Q2 2017 Aug 17, 2017	BUY	N/A	33,186	33,186 $3.01 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Biomarin Pharmaceutical Inc Transaction History